Medical Developments International Management
Management criteria checks 2/4
Medical Developments International's CEO is Brent MacGregor, appointed in Nov 2020, has a tenure of 4.08 years. total yearly compensation is A$6.17M, comprised of 9.8% salary and 90.2% bonuses, including company stock and options. directly owns 0.2% of the company’s shares, worth A$91.69K. The average tenure of the management team and the board of directors is 4.2 years and 4.2 years respectively.
Key information
Brent MacGregor
Chief executive officer
AU$6.2m
Total compensation
| CEO salary percentage | 9.8% |
| CEO tenure | 4.1yrs |
| CEO ownership | 0.2% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
Positive Sentiment Still Eludes Medical Developments International Limited (ASX:MVP) Following 27% Share Price Slump
May 13
Is Medical Developments International (ASX:MVP) In A Good Position To Invest In Growth?
May 03Why Investors Shouldn't Be Surprised By Medical Developments International Limited's (ASX:MVP) 28% Share Price Plunge
Mar 11Medical Developments International Limited (ASX:MVP) Soars 28% But It's A Story Of Risk Vs Reward
Jan 16Will Medical Developments International (ASX:MVP) Spend Its Cash Wisely?
Jan 03Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
Aug 09We're Keeping An Eye On Medical Developments International's (ASX:MVP) Cash Burn Rate
Apr 24Is Medical Developments International (ASX:MVP) In A Good Position To Deliver On Growth Plans?
Jul 04Some Analysts Just Cut Their Medical Developments International Limited (ASX:MVP) Estimates
Mar 04Medical Developments International Limited (ASX:MVP) Analysts Just Slashed This Year's Estimates
Mar 05If You Had Bought Medical Developments International (ASX:MVP) Shares Five Years Ago You'd Have Earned 56% Returns
Feb 07Don't Ignore The Fact That This Insider Just Sold Some Shares In Medical Developments International Limited (ASX:MVP)
Dec 16Medical Developments International Limited's (ASX:MVP) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Dec 10
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$6m | AU$602k | -AU$41m |
| Mar 31 2024 | n/a | n/a | -AU$30m |
| Dec 31 2023 | n/a | n/a | -AU$19m |
| Sep 30 2023 | n/a | n/a | -AU$12m |
| Jun 30 2023 | AU$2m | AU$576k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$4m |
| Dec 31 2022 | n/a | n/a | -AU$2m |
| Sep 30 2022 | n/a | n/a | -AU$7m |
| Jun 30 2022 | AU$2m | AU$547k | -AU$12m |
| Mar 31 2022 | n/a | n/a | -AU$16m |
| Dec 31 2021 | n/a | n/a | -AU$19m |
| Sep 30 2021 | n/a | n/a | -AU$16m |
| Jun 30 2021 | AU$1m | AU$351k | -AU$13m |
Compensation vs Market: Brent's total compensation ($USD3.83M) is above average for companies of similar size in the Australian market ($USD286.38K).
Compensation vs Earnings: Brent's compensation has increased whilst the company is unprofitable.
CEO
Brent MacGregor (60 yo)
4.1yrs
Tenure
AU$6,166,500
Compensation
Mr. Brent MacGregor serves as an Independent Director at Dynavax Technologies Corporation since July 2020. He has been the Chief Executive Officer of Medical Developments International Limited since Novemb...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 4.1yrs | AU$6.17m | 0.20% A$ 91.7k | |
| Chief Financial Officer | 2.6yrs | AU$5.94m | 0.056% A$ 25.5k | |
| Head of Operations & Supply Chain | no data | no data | no data | |
| Chief Scientific Officer | 5.4yrs | no data | no data | |
| General Counsel & Company Secretary | 2.3yrs | no data | no data | |
| Head of People & Culture | no data | no data | no data | |
| Head of Production | 4.4yrs | no data | no data | |
| Head of Europe | 4.3yrs | no data | no data | |
| Head of Medical Affairs & Clinical Development | no data | no data | no data | |
| Global Head of Respiratory | no data | no data | no data | |
| Head of Quality & Regulatory Affairs | no data | no data | no data | |
| Acting Head of Medical Affairs & Clinical Development | no data | no data | no data |
4.2yrs
Average Tenure
Experienced Management: MVP's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Non-Executive Chairman | 4.2yrs | AU$95.00k | 0.84% A$ 385.0k | |
| Non-Executive Director | 1.3yrs | AU$50.00k | 0.014% A$ 6.4k | |
| Non-Executive Director | 11.3yrs | AU$60.00k | 0.055% A$ 25.1k | |
| Non-Executive Director | 3.6yrs | AU$60.00k | 0.021% A$ 9.5k | |
| Non-Executive Director | 4.6yrs | AU$60.00k | 0.080% A$ 36.7k |
4.2yrs
Average Tenure
Experienced Board: MVP's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 17:56 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medical Developments International Limited is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Dennis Hulme | APP Securities Pty Ltd. |
| Anubhav Saxena | Bell Potter |
| Martyn Jacobs | Canaccord Genuity |